Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
R.D. Solorzano
April 21, 2026
ARPA-H Is Funding the Regeneration of Human Joints, and the Biofabrication Implications Go Further Than Osteoarthritis
R.D. Solorzano
April 9, 2026
The $150 Bioprinter Extruder That Anyone Can Build
R.D. Solorzano
April 8, 2026
Cellbricks Therapeutics Raises €10M to Advance Biofabricated Tissue Implants for Wound Care and Reconstructive Surgery
R.D. Solorzano
April 6, 2026
NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication
R.D. Solorzano
April 5, 2026
Canada Just Bet Another $280M on Bioprinted Medicines, Here’s What It Means for the Industry
R.D. Solorzano
March 8, 2026
UC San Diego’s ARPA-H Project Targets the A Different Approach for the Bioprinted LIVER Program
R.D. Solorzano
March 6, 2026
Japan Moves Toward First Commercial iPS Cell Therapies
R.D. Solorzano
March 3, 2026
Cellares Raises $257M to Industrialize Cell Therapy Manufacturing
R.D. Solorzano
February 26, 2026
UT Southwestern VITAL Program Wins ARPA-H Award to Bioprint Personalized, Immune-Compatible Livers
R.D. Solorzano
February 20, 2026
United Therapeutics Reports Breakthrough Phase 1 Results for Bioengineered Liver Support System
R.D. Solorzano
Previous Page
1
2
3
4
…
14
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Already have a WordPress.com account?
Log in now.
The Business of Biofabrication
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
The Business of Biofabrication 